Cargando…
Real-time PCR/MCA assay using fluorescence resonance energy transfer for the genotyping of resistance related DHPS-540 mutations in Plasmodium falciparum
BACKGROUND: Sulphadoxine-pyrimethamine has been abandoned as first- or second-line treatment by most African malaria endemic countries in favour of artemisinin-based combination treatments, but the drug is still used as intermittent preventive treatment during pregnancy. However, resistance to sulph...
Autores principales: | Mens, Petra F, van Overmeir, Chantal, Bonnet, Maryline, Dujardin, Jean-Claude, d'Alessandro, Umberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276220/ https://www.ncbi.nlm.nih.gov/pubmed/18346279 http://dx.doi.org/10.1186/1475-2875-7-48 |
Ejemplares similares
-
Multiple Origins and Regional Dispersal of Resistant dhps in African Plasmodium falciparum Malaria
por: Pearce, Richard J., et al.
Publicado: (2009) -
Safety and efficacy of lumefantrine-artemether (Coartem(®)) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults
por: Mulenga, Modest, et al.
Publicado: (2006) -
Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum
por: Flegg, Jennifer A, et al.
Publicado: (2013) -
PCR detection of Plasmodium falciparum in human urine and saliva samples
por: Mharakurwa, Sungano, et al.
Publicado: (2006) -
Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays
por: Wilson, Danny W, et al.
Publicado: (2010)